LN
Clinical trials for LN explained in plain language.
Never miss a new study
Get alerted when new LN trials appear
Sign up with your email to follow new studies for LN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental drug tested to control protein leak in damaged kidneys
Disease control TerminatedThis study tested whether an experimental drug called OMS721 (narsoplimab) was safe and could reduce protein in the urine for adults with certain serious kidney diseases. It involved 31 participants with conditions like IgA nephropathy, lupus nephritis, and others, who received t…
Matched conditions: LN
Phase: PHASE2 • Sponsor: Omeros Corporation • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New drug trial aims to protect kidneys in autoimmune diseases
Disease control TerminatedThis study tested an investigational drug, ALXN2050, in adults with two serious kidney diseases: lupus nephritis and IgA nephropathy. The goal was to see if adding ALXN2050 to standard care could better reduce protein in the urine and protect long-term kidney function. The trial …
Matched conditions: LN
Phase: PHASE2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC